Perspective of Precision Therapy on Lung Cancer
Lung cancer remains to have the highest morbidity and mortality rates in China among known malignant tumors. Novel drugs and regimens have been sought because of the limited efficiency of traditional chemotherapy and radiotherapy in lung cancer treatment. In the last 20 years, rapid developments in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2023-05-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1208 |
| _version_ | 1797808909552975872 |
|---|---|
| author | REN Shengxiang QIU Tianyu |
| author_facet | REN Shengxiang QIU Tianyu |
| author_sort | REN Shengxiang |
| collection | DOAJ |
| description | Lung cancer remains to have the highest morbidity and mortality rates in China among known malignant tumors. Novel drugs and regimens have been sought because of the limited efficiency of traditional chemotherapy and radiotherapy in lung cancer treatment. In the last 20 years, rapid developments in molecular targeted therapy and immunotherapy have increased clinical efficacy and benefitted patients with cancer. Treatments for lung cancer are the most rapidly developed among treatments for solid tumors, pioneering tumor precision medicine. This manuscript reviews the evolution and development of targeted therapy and immunotherapy and discusses existing problems and future directions in the precision therapy of lung cancer. |
| first_indexed | 2024-03-13T06:44:41Z |
| format | Article |
| id | doaj.art-d612611fff44418a883dafe123f310e4 |
| institution | Directory Open Access Journal |
| issn | 1000-8578 |
| language | zho |
| last_indexed | 2024-03-13T06:44:41Z |
| publishDate | 2023-05-01 |
| publisher | Magazine House of Cancer Research on Prevention and Treatment |
| record_format | Article |
| series | Zhongliu Fangzhi Yanjiu |
| spelling | doaj.art-d612611fff44418a883dafe123f310e42023-06-08T10:42:08ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782023-05-0150544245110.3971/j.issn.1000-8578.2023.22.12088578.2023.22.1208Perspective of Precision Therapy on Lung CancerREN Shengxiang0QIU Tianyu1Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, ChinaDepartment of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai 200433, ChinaLung cancer remains to have the highest morbidity and mortality rates in China among known malignant tumors. Novel drugs and regimens have been sought because of the limited efficiency of traditional chemotherapy and radiotherapy in lung cancer treatment. In the last 20 years, rapid developments in molecular targeted therapy and immunotherapy have increased clinical efficacy and benefitted patients with cancer. Treatments for lung cancer are the most rapidly developed among treatments for solid tumors, pioneering tumor precision medicine. This manuscript reviews the evolution and development of targeted therapy and immunotherapy and discusses existing problems and future directions in the precision therapy of lung cancer.http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1208lung cancerprecision medicinemolecular targeted therapyimmunotherapy |
| spellingShingle | REN Shengxiang QIU Tianyu Perspective of Precision Therapy on Lung Cancer Zhongliu Fangzhi Yanjiu lung cancer precision medicine molecular targeted therapy immunotherapy |
| title | Perspective of Precision Therapy on Lung Cancer |
| title_full | Perspective of Precision Therapy on Lung Cancer |
| title_fullStr | Perspective of Precision Therapy on Lung Cancer |
| title_full_unstemmed | Perspective of Precision Therapy on Lung Cancer |
| title_short | Perspective of Precision Therapy on Lung Cancer |
| title_sort | perspective of precision therapy on lung cancer |
| topic | lung cancer precision medicine molecular targeted therapy immunotherapy |
| url | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1208 |
| work_keys_str_mv | AT renshengxiang perspectiveofprecisiontherapyonlungcancer AT qiutianyu perspectiveofprecisiontherapyonlungcancer |